GlassScriptPhysician profile
Evan Roy Meeks
NPI 1376533869
$363.41
in general payments reported to CMS, 2019-2025
9 companies · $121 in 2025
The $121 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.03 · 2022: $14.52 · 2023: $151 · 2024: $62.35 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $334.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $97.68 | 2023 | Dexcom G6 Transmitter |
| Corium, LLC | $89.03 | 2025 | Azstarys |
| Novo Nordisk INC | $61.74 | 2021-2023 | Rybelsus, Ozempic |
| Xeris Pharmaceuticals, INC. | $24.44 | 2024 | Gvoke Hypopen |
| Ironshore Pharmaceuticals INC. | $20.65 | 2024 | |
| Supernus Pharmaceuticals, INC. | $20.20 | 2023 | Qelbree |
| Astrazeneca Pharmaceuticals LP | $17.26 | 2024 | Airsupra |
| Glaxosmithkline, LLC. | $16.86 | 2025 | Shingrix, Bexsero |
| Ars Pharmaceuticals Operations, INC. | $15.55 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Meeks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.